Please login to the form below
24
Revenue 2017Daiichi Sankyo
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.
Improving diagnosis and treatment of advanced lung cancer
by Ruder Finn UK for Daiichi Sankyo Europe GmbH. ... The Future of Anticoagulation Report - Evolving thought leadership in atrial fibrillation - by Ruder Finn UK for Daiichi Sankyo Europe GmbH.
Finalists revealed for Communiqué Awards 2016
by Ruder Finn. for Daiichi Sankyo Europe GmbH. Dispensing Health for Pharmacy Voice.
BioMarin gives up on muscular dystrophy drug
Meanwhile, Daiichi Sankyo has also started clinical trials of an exon-skipping therapy, called DS-5141b, but says it does not expect to bring it to market until 2020.
Daiichi pulls study of patritumab in lung cancer
Daiichi Sankyo has halted a late-stage trial of its HER3 inhibitor patritumab after seeing no evidence of efficacy at an interim analysis. ... The antibody was developed by Daiichi Sankyo's German subsidiary U3 Pharma, which is being shut down alongside
Otsuka joins its Japanese peers on Twitter
Many of Otsuka's fellow Japanese pharma companies have been using Twitter for some time, with Daiichi Sankyo making the most extensive use with seven accounts, including ones for Europe, Spain
[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- STEM Healthcare founder Rob Wood secures a 25% stake in performance-io
- Sinopharm’s COVID-19 vaccine scores approval in China
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AZ sells stake in Moderna for around $1.2bn
- Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Gene Editing and Precision Medicine: The Future of Healthcare?
- CRM Design and Optimization for Life Science Organizations
- EMA begins rolling review process for Sputnik V COVID-19 vaccine
- MHRA to fast-track vaccines modified for new COVID-19 variants
- Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
- Syneos Health Communications announces senior hires to Europe-based team
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
